Dietz A, Rudat V, Nollert J, Helbig M, Vanselow B, Weidauer H
HNO-Klinik, Universität Heidelberg.
HNO. 1998 Aug;46(8):731-8. doi: 10.1007/s001060050303.
In addition to mucositis and myelotoxicity as well known early reactions after radiotherapy or radiochemotherapy in advanced head and neck tumors, late toxicity following treatment is an often underestimated problem. Between 1992 and 1995, 68 patients with advanced oro- and hypopharyngeal tumors were treated primarily with accelerated concomitant boost radiochemotherapy (total dose irradiations of 66 Gy and carboplatin as chemotherapy). Ninety-three per cent of the patients had stage IV disease according to the UICC-TNM classification. Monitoring of follow-up included late toxicity with special attention given to laryngeal edema. In 37 patients (54%) edema of the larynx as a late complication of radiochemotherapy was observed by clinical investigation and CT scan. The median onset of laryngeal edema was found 121 days after completion of therapy, with a median time of observation of 250 days. Observations in these patients demonstrated the chronic character of this edema. An increase in the laryngeal edema in 5 cases resulted in tracheostomy. Laryngeal edema in 10 patients was associated with recurrence of tumor. These results show that after xerostomia laryngeal edema is the main late toxicity in the head and neck after radiochemotherapy and should lead to further investigations to exclude possible recurrent tumor.
除了黏膜炎和骨髓毒性作为晚期头颈肿瘤放疗或放化疗后众所周知的早期反应外,治疗后的晚期毒性是一个经常被低估的问题。1992年至1995年期间,68例晚期口咽和下咽肿瘤患者主要接受加速同步推量放化疗(总剂量照射66 Gy,卡铂作为化疗药物)。根据UICC-TNM分类,93%的患者为IV期疾病。随访监测包括晚期毒性,特别关注喉水肿。通过临床检查和CT扫描,在37例患者(54%)中观察到喉水肿作为放化疗的晚期并发症。喉水肿的中位发病时间为治疗结束后121天,中位观察时间为250天。对这些患者的观察表明了这种水肿的慢性特征。5例患者的喉水肿加重导致了气管切开术。10例患者的喉水肿与肿瘤复发有关。这些结果表明,在口干之后,喉水肿是放化疗后头颈部位主要的晚期毒性,应进一步检查以排除可能的肿瘤复发。